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Herpes zoster (HZ), also known as shingles, is an acute infection of viral origin resulting from the reactivation of the varicella zoster virus (VZV), which causes chicken 
pox [1]. HZ typically erupts within one or two adjacent dermatomes, 
with thoracic (50–60%), cervical (10–20%), and trigeminal (10–
20%) being more commonly involved, while lumbar (5–10%) and 
sacral (5%) are other less commonly involved dermatomes. In 
immunocompetent patients, the involvement of non-contiguous 
dermatomes is never seen, although overlapping of adjacent 
dermatomes can be shown in 20% of cases [2]. The involvement 
of maxillary and mandibular branches without the involvement 
of the ophthalmic branch accounts for 1.7% [3] –2% [4] of total 
cases of HZ, which is comparatively rare [3].
This case series is an attempt to highlight the various clinical 
presentations of HZ infections with the rarity of involvement 
of more than one division of the trigeminal nerve showing 
manifestations both in the orofacial region and in the intraoral 
site in the affected individual.
CASE REPORT
Case 1
A 42-year-old female patient reported with the complaint of pain 
in the upper left side of the jaw for 2 days and also discomfort 
with burning sensation during food intake. The patient gave a 
history of the appearance of 4–5 vesicles 3 days back on the hard 
palate following their rupture to form ulcer which was associated 
with pain. The pain was mild, continuous, and radiating in nature; 
aggravated while eating, drinking, and swallowing but did not 
get relieved. The pain was also associated with fever of low 
grade for 5 days. She also gave a history of chicken pox in the 
childhood. Extraoral examination showed no significant findings. 
Intraoral examination revealed multiple ulcers in relation to the 
left side of the hard palate, measuring approximately 0.5–1 cm in 
diameter, irregular in shape surrounded by an erythematous halo, 
and not crossing the midline (Fig. 1a). The ulcers were tender on 
palpation. Based on the above findings, a provisional diagnosis of 
HZ infection of the left maxillary division of the trigeminal nerve 
was considered.
Case 2
A 34-year-old male patient reported to the clinic complaining of 
painful blisters on the left side of his face and painful ulcers in 
the mouth for the past 5 days. Detailed history revealed that the 
lesions were preceded by the fever of low grade. 2–3 days after 
the fever, he developed fluid-filled blisters on the left side of his 
face. Initially, the blisters were small in size and few in number, 
but later, they increased in number covering the entire left half 
of the face with a watery discharge. It was also associated with 
pain which was severe, continuous, and radiating in nature. He 
also gave a complaint of difficulty in eating and swallowing. The 
patient gave a history of chicken pox infection in the childhood. 
No relevant drug, dental, and family history were recorded. 
Extraoral examination revealed clusters of vesicles on the left half 
of face extending from the temple region to the left chin region, 
which stopped abruptly at the midline. The surrounding skin was 
very tender on palpation (Fig. 2a). Intraoral examination showed 
numerous ruptured vesicles, which coalesced to form large ulcers 
that measured approximately 1–2 cm in size on the left half of 
the hard palate, not crossing the midline (Fig. 2b). The ulcers 
were irregular in shape with sloped edges and were surrounded 
by an erythematous halo. There was tender on palpation. Vitals 
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were normal at the time of examination. Routine hematological 
and serological investigations were performed for the patient. 
Complete blood count was found to be within normal limits 
except erythrocyte sedimentation rate and red blood cell which 
were slightly raised. The cytological examination was done after 
obtaining the smear from the lesions presented intraorally and 
extraorally. Acantholytic cells with few exfoliated squamous 
cells and inflammatory cells were revealed in the cytological 
smear. Based on the history, clinical findings, and cytological 
examination, a final diagnosis of HZ infection was given.
Case 3
A 57-year-old female patient reported with the chief complaint of 
ulcers on the left side of the palate for 7 days (Fig. 3a). The patient 
gave a history of pain in the left side of the palate for 7 days which 
got aggravated for the past 3 days. The pain was continuous and 
severe. There was no history of fever and malaise. There was no 
evidence of any vesiculation or ulceration extraorally. On intraoral 
examination, multiple small ulcers were observed on the left side 
of the palate with a unilateral arrangement in a linear pattern. The 
ulcers were irregular in shape extending anteroposteriorly from 
distal of the upper left second premolar to distal of the second 
molar and mediolaterally from mid of the hard palate to the 
interdental gingiva in relation to the upper left first molar, and the 
second molar. No such lesions were observed anywhere else in 
the oral cavity. Based on the above-mentioned clinical findings, a 
provisional diagnosis of HZ infection involving the left maxillary 
division of the trigeminal nerve was considered.
In all the three cases, the patients were treated with antiviral 
drugs and supportive therapy for 1 week. Acyclovir 800 mg 
(5 times a day for 7 days) was prescribed to control the active 
viral phase. Topical application of acyclovir cream (5%), 3 times 
a day, was also advised to apply in the affected region till complete 
resolution of the erythema. Aceclofenac (100 mg) in combination 
with acetaminophen (325 mg) and serratiopeptidase (15 mg) was 
prescribed, twice daily for symptomatic relief of pain and fever. 
Lignocaine gel (2%) was prescribed for local application before 
meals and betadine mouthwash to improve oral hygiene.
After 1 week of follow-up, in case one, the number of 
intraoral lesions was regressed (Fig. 1b). No fresh vesicles were 
reported. The patient was then again reviewed after 1 week and 
complete resolution of the lesions was noticed (Fig. 1c). After 
1-month follow-up, the patient was totally asymptomatic and 
no post-therapeutic complications were reported. In case two, 
after 1 week, significant regression of a number of extraoral 
lesions was noted with the formation of scar tissue (Fig. 2c). 
Furthermore, resolution of the lesions was noticed intraorally 
(Fig. 2d). On further follow-up, after 2 weeks, the lesion was 
completely resolved, both extraorally and intraorally (Fig. 2e and 
f); and the patient was completely asymptomatic. In case three, 
on follow-up examination, significant regression in the lesion was 
observed 1 week after the institution of treatment (Fig. 3b). The 
ulcers were completely resolved on further follow-up visit after 
3 weeks (Fig. 3c).
Figure 1: Case 1 - (1a) Pre-treatment intraoral photograph; (1b) after 
7-day follow-up visit; (1c) after 1-month follow-up visit
Figure 2: Case 2 - (2a) Pre-treatment extraoral photograph; (2b) pre-
treatment intraoral photograph; (2c and 2d) after 1-week follow-up 
visit; (2e and 2f) complete resolution of lesion both extraorally and 
intraorally after 2 weeks
Figure 3: Case 3 - (3a) Pre-treatment intraoral photograph; (3b) after 
1 week; (3c) after 3 weeks, complete resolution of the lesiona b c
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DISCUSSION
VZV is responsible for two major clinical infections of humans: 
the chicken pox or varicella (primary infection) and shingles or 
HZ. HZ is caused by reactivation of latent virus acquired during 
varicella [5]. Reactivation of VZV may occur spontaneously or 
when host immunity is compromised. Increased age, physical 
trauma (including dental procedures), psychological stress, 
malignancy, radiation therapy, and immunocompromised states 
including transplant recipients; steroid therapy and HIV infection 
are the predisposing factors for VZV reactivation [6]. The 
pathogenesis of the VZV infection has been depicted in Fig. 4. To 
get up-to-date information, a web-based search was initiated using 
PubMed/Medline database, searching for recent and relevant case 
reports of HZ written in English (Table 1).
The disease is more common in adult life and affects males 
and females in equal frequency. This is also evident from the 
cases reviewed (Table 1) that the age ranged from 23 to 80 years 
with the majority of HZ cases occurred in patients above the age 
of 40 years. HZ may affect any sensory ganglia and its cutaneous 
nerve; predominantly, the dermatomes innervated by spinal cord 
segment T3–L2; however, approximately 13% of the patients 
present with infections involving any of the three branches of 
the trigeminal nerve [5,7]. The ophthalmic division (V1) of the 
trigeminal nerve is most commonly affected presenting lesions on 
the upper eyelid, forehead, and scalp. Involvement of maxillary 
division (V2) shows lesions on the midface, upper lip, on the hard 
palate, and/or, buccal gingiva on one side which is preceded by 
prodrome and with mandibular division (V3) shows lesions on the 
lower face, lower lips, on mandibular gingivae, and tongue [8]. 
Among the case reports summarized in Table 1, the incidence of 
involvement of maxillary division is found to be predominant, 
followed by mandibular division. In our cases also, maxillary 
division of the trigeminal nerve was involved in case 1 and 3; 
while both maxillary and mandibular division are involved in 
case 2.
The common duration for shingle is a 2–3 days of prodromal 
phase characterized by deep intense pain over the affected 
nerve distribution. The prodromal phase begins 2–4 days before 
the appearance of the mucocutaneous rashes or vesicles. The 
presentation of prodromal pain is dermatomic in nature and may 
be associated with fever, malaise, and headache [9-11]. Similar 
findings were reported in all the three of our cases. This is 
followed by the acute phase, characterized by the development of 
clustered vesicles in a linear fashion alongside the affected nerve, 
unilaterally. Within a period of 3–4 days, the vesicles become 
pustular and ulcerate followed by the formation of scab usually in 
7–10 days, although, it might take around 2–3 weeks for the lesions 
to go for complete resolution in otherwise healthy patients [9]. 
The active or “eruptive” phase of HZ is most contagious and can 
pose a significant risk of cross-infection [12].
Oral lesions occur with trigeminal nerve involvement, which 
may involve both the movable and bound mucosa, unilaterally [9]. 
Oral lesions appear as white opaque vesicles which rupture to 
form areas of shallow ulcerations, which are extremely painful. 
Ulcers are 1–5 mm in size and often coalesce to form larger ulcers 
with scalloped borders [8]. In all our cases, the patient came 
during the active stage of disease with the characteristic unilateral 
presentation of lesions. When trigeminal HZ occurs during tooth 
formation, pulpal necrosis and internal root resorption may 
occur [8]. Periapical lesions [13], tooth exfoliation [14], and 
alveolar osteonecrosis [15] have also been reported in association 
with HZ infection. Complete healing typically takes another 
2–4 weeks. After complete healing ensues, scarring with areas 
of hypopigmentation or hyperpigmentation can be seen. When 
the dermatomal pain of HZ infections might occur without the 
appearance of rashes, it is being referred as zoster sine herpete [9].
The most common and debilitating complication of HZ 
infection is post-herpetic neuralgia (PHN), characterized by 
pain that lasts for almost 1–3 months after the lesions are 
cleared [15-18]. Secondary bacterial infection is another common 
complication of HZ [15]. If the geniculate ganglion is involved, 
it may result in James Ramsay Hunt’s syndrome, which includes 
facial paralysis and painful vesicular eruptions of the external 
auditory meatus and pinna of the ear [19]. Other complications 
include scarring of skin, keratitis, retinal necrosis causing 
blindness, keratouveitis, cranial and peripheral nerve palsies, 
cerebral ataxia, and pneumonia may lead to death [19]. According 
to Whitley et al. [20], most frequent zoster-related complication, 
excluding PHN were neurological (1.4%) and ocular (0.7%) 
in non-vaccinated individuals, and cutaneous (0.7%) and 
neurological (0.5%) in vaccinated individuals.
Diagnosis of HZ infections can often be made from clinically 
by its unique unilateral distribution of the lesions. Identification 
of the virus in the cell culture of human fibroblasts is still the best 
diagnostic modality which reveals multinucleated epithelial cells, Figure 4: Pathogenesis of the varicella zoster virus infection
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Table 1: Cases of HZ reported in literature
Author Year Age/
Sex
Division of trigeminal nerve 
involved
Treatment Recurrence on 
follow-up
Raj et al. [5] 2017 55/M Right maxillary division Acyclovir 800 mg 5 times daily for 5 days; Tab. 
prednisolone 5 mg 3 times daily for 5 days; Tab. 
paracetamol 650 mg
No
Tayde et al. [18] 2017 28/F Left maxillary division Acyclovir 800 mg 5 times per day for 7 days No
23/F Right maxillary division Acyclovir 600 mg 5 times per day for 7 days No
65/F Right maxillary division Acyclovir 800 mg 5 times per day for 7 days
Ali et al. [22] 2016 50/M Right maxillary and 
mandibular division
Acyclovir 400 mg/5 h for 2 weeks No
Rai et al. [23] 2016 43/m Left maxillary and 
mandibular division
Acyclovir 800 mg 5 times per day for 7 days No
Chhimwal et al. [24] 2015 42/M Left maxillary division Acyclovir 800 mg 5 times per day for 10 days
Aceclofenac 500 mg thrice daily
Betadine mouthwash
No
Nair et al. [15] 2014 68/M Left maxillary and 
mandibular division
Valacyclovir 1 g 3 times a day for 7 days No
50/M Left maxillary, mandibular, 
and ophthalmic division
Acyclovir 800 mg 5 times per day for 10 days No
Vineet et al. [6] 2013 53/M Left maxillary division Acyclovir 800 mg 5 times per day for 10 days No
Mohan et al. [25] 2013 80/F Maxillary division Acyclovir 800 mg 5 times per day for 10 days No
HZ: Herpes zoster
Table 2: Treatment modalities for herpes zoster infection
Antiviral treatment
Antiviral treatment (guanosine analogs) should be instituted within 72 h of cutaneous eruption because most virus replication ceases 72 h after 
onset of rash [5,11].
Acyclovir
Drug of choice
Dose - 800 mg, 5 times a day for 7–10 days
Mechanism - shortens the duration of viral shedding, inhibits the formation of new lesions, hastens healing, and reduces the severity of acute 
pain.
Valacyclovir
A prodrug of acyclovir
Dose - 1000 mg, 3 times a day for 7 days
It produces a serum acyclovir level 3–5 times as high as that achieved with oral acyclovir therapy
Corticosteroids [5,11]
The use of corticosteroids in the treatment of HZ has been controversial. Their benefits are overshadowed by fear of reduced immune response,    
and hence, they are contraindicated in immunocompromised patients
However, in combination with acyclovir, they show moderate but significant acceleration in the rate of cutaneous healing and also alleviate acute 
pain. However, no study demonstrated any effect of corticosteroids on the incidence or duration of PHN
The use of corticosteroids for HZ without concomitant antiviral therapy is not recommended [26]
Tricyclic antidepressants[11]
Capsaicin is the only topical preparation approved for temporary relief of pain associated with HZ infections
It should not be applied until skin lesions have healed
Recent treatment modalities[5]
Lysine/arginine - usually given at 300–1200 mg dosage per day
Topical zinc treatment - applied as topical solution of zinc sulfate (4%) in water 4 times daily for 4 days
Vitamin C - given as 200 mg ascorbic acid and 200 mg as water-soluble flavonoids (apparently from citrus) 3 times daily for 3 days
Oral zinc treatment - which includes oral administration of 23 mg zinc sulfate and 250 mg Vitamin C, each twice daily for 6 weeks
Vitamin E - topical application of Vitamin E relieved pain and aided in the healing of oral herpetic lesions. The affected area was dried and cotton 
saturated with Vitamin E oil (20,000–28,000 IU per ounce) was placed over it for 15 min
Adenosine monophosphate is also given; each injection contained 1.5–2.0 mg/kg body weight and was administered every other day for a total   
of 9–12 treatments
Newer medications [6,11]
CMX 001 hexadecyloxypropyl-cidofovir
Valacyclovir nucleoside analog (H2G)
ASP2151 helicase-primase inhibitor
FV100 two bicyclic nucleoside analogs
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although, it does not distinguish between herpes simplex virus 
and VZV. The other methods with higher sensitivity and rapid 
diagnosis are direct immunofluorescence antibody detection 
against VZV, giving positive results in up to 80% of the cases. 
Polymerase chain reaction detects viral antigen. In recurrent 
cases, increased immunoglobulin M (IgM) levels are detectable in 
serum 10 days after the appearance of the vesicles and increased 
IgG and IgA 4 days after the vesicles [9,10,21].
Although it is a self-limiting disease, early institution 
of antiviral and symptomatic therapy reduces the morbidity 
significantly (Table 2). Symptomatic treatment such as keeping 
cutaneous lesions clean and dry, use of sterile non-adherent 
dressing over skin to protect the lesions, topical applications 
(i.e. calamine lotion), sympathetic nerve blockades, and analgesics 
(aspirin and others) may be used, as was advised in both our cases 
and helped speedup recovery.
CONCLUSION
This case series signifies the importance of a thorough medical, 
dental case history, and examination of the patients with sporadic 
diseases such as HZ. Early diagnosis and prompt treatment by 
antiviral drugs in the acute stage of the HZ may aid in reducing 
the duration and the severity of pain of HZ infection and also 
prevent the complications.
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